A detailed history of Itau Unibanco Holding S.A. transactions in Moderna, Inc. stock. As of the latest transaction made, Itau Unibanco Holding S.A. holds 670 shares of MRNA stock, worth $24,689. This represents 0.0% of its overall portfolio holdings.

Number of Shares
670
Previous 629 6.52%
Holding current value
$24,689
Previous $74,000 40.54%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$63.64 - $125.14 $2,609 - $5,130
41 Added 6.52%
670 $44,000
Q2 2024

Aug 13, 2024

BUY
$101.21 - $166.61 $63,661 - $104,797
629 New
629 $74,000
Q4 2023

Feb 14, 2024

BUY
$69.51 - $104.43 $29,124 - $43,756
419 Added 39.57%
1,478 $146,000
Q3 2023

Nov 14, 2023

SELL
$96.41 - $126.61 $31,429 - $41,274
-326 Reduced 23.54%
1,059 $109,000
Q2 2023

Aug 14, 2023

BUY
$118.5 - $160.53 $80,224 - $108,678
677 Added 95.62%
1,385 $168,000
Q1 2023

May 12, 2023

SELL
$135.66 - $197.02 $133,625 - $194,064
-985 Reduced 58.18%
708 $108,000
Q4 2022

Feb 09, 2023

SELL
$118.38 - $210.04 $22,847 - $40,537
-193 Reduced 10.23%
1,693 $304,000
Q3 2022

Nov 14, 2022

SELL
$118.07 - $194.18 $32,587 - $53,593
-276 Reduced 12.77%
1,886 $223,000
Q2 2022

Aug 15, 2022

BUY
$117.13 - $176.59 $81,288 - $122,553
694 Added 47.28%
2,162 $309,000
Q1 2022

May 16, 2022

BUY
$126.46 - $235.05 $64,241 - $119,405
508 Added 52.92%
1,468 $253,000
Q4 2021

Feb 14, 2022

BUY
$225.82 - $368.51 $36,582 - $59,698
162 Added 20.3%
960 $242,000
Q3 2021

Nov 12, 2021

BUY
$221.9 - $484.47 $48,374 - $105,614
218 Added 37.59%
798 $307,000
Q2 2021

Aug 17, 2021

BUY
$129.91 - $234.98 $75,347 - $136,288
580 New
580 $136,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Itau Unibanco Holding S.A. Portfolio

Follow Itau Unibanco Holding S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Itau Unibanco Holding S.A., based on Form 13F filings with the SEC.

News

Stay updated on Itau Unibanco Holding S.A. with notifications on news.